294837
Cloruro de hidrógeno solution
1.0 M in diethyl ether
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula empírica (notación de Hill):
HCl
Número CAS:
Peso molecular:
36.46
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352301
MDL number:
Concentration:
0.95-1.10 M (with NaOH, titration), 1.0 M in diethyl ether
Form:
liquid
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleform
liquid
Quality Level
concentration
0.95-1.10 M (with NaOH, titration), 1.0 M in diethyl ether
density
0.731 g/mL at 25 °C
storage temp.
2-8°C
SMILES string
Cl
InChI
1S/ClH/h1H
InChI key
VEXZGXHMUGYJMC-UHFFFAOYSA-N
General description
Hydrogen chloride solution (1.0 M in diethyl ether) is generally prepared by passing HCl gas through diethyl ether solvent. It is suitable for air/moisture-sensitive reactions.
Application
Hydrogen chloride solution (1.0 M in diethyl ether) can be used in the synthesis of molybdenum adamantylimido and t-butylimido alkylidene chloride complexes in the presence of PPh2Me. It is also used in some cyclization reactions, for example, in the cyclization of oxadiazole derivatives from corresponding thiosemicarbazides.
Still not finding the right product?
Explore all of our products under Cloruro de hidrógeno solution
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Flam. Liq. 2 - Met. Corr. 1 - STOT SE 3
target_organs
Central nervous system
supp_hazards
Clase de almacenamiento
3 - Flammable liquids
wgk
WGK 1
flash_point_f
-40.0 °F - closed cup
flash_point_c
-40 °C - closed cup
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to
Ann Brinkmalm et al.
Molecular neurodegeneration, 9, 53-53 (2014-11-25)
Synaptic degeneration is an early pathogenic event in Alzheimer's disease, associated with cognitive impairment and disease progression. Cerebrospinal fluid biomarkers reflecting synaptic integrity would be highly valuable tools to monitor synaptic degeneration directly in patients. We previously showed that synaptic
Mahsa Sadeghi et al.
British journal of pharmacology, 172(2), 460-468 (2014-01-01)
Tapentadol is a novel analgesic that combines moderate μ-opioid receptor agonism and noradrenaline reuptake inhibition in a single molecule. Both mechanisms of action are involved in producing analgesia; however, the potency and efficacy of tapentadol in individual neurons has not